Related Experiment Video

Updated: Aug 13, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

[Surgical treatment of nonspecific ulcerative colitis in children]

N N Kanshin, O A Kanshina

    Vestnik Khirurgii Imeni I. I. Grekova
    |December 1, 1980
    PubMed

    Insights

    Surgical intervention for pediatric ulcerative colitis is recommended when conservative treatments fail. This two-step surgical approach involves colon removal and bowel reconstruction for improved outcomes in children.

    Area of Science:

    • Pediatric Gastroenterology
    • Surgical Gastroenterology
    • Inflammatory Bowel Disease Research

    Background:

    • Nonspecific ulcerative colitis (UC) presents a significant challenge in pediatric populations.
    • Current conservative treatments for pediatric UC have limitations in efficacy.
    • Evaluating surgical interventions is crucial for refractory cases.

    Observation:

    • The study analyzed the treatment experience of 285 children diagnosed with nonspecific ulcerative colitis.
    • Conservative management proved ineffective for a subset of patients, necessitating alternative strategies.
    • Surgical treatment was considered for both severe and mild cases unresponsive to medical therapy.

    Findings:

    • Surgical treatment should be more widely recommended for pediatric nonspecific ulcerative colitis when conservative methods fail.
    • A two-step surgical procedure is proposed: 1) complete colectomy with ileorectal anastomosis, and 2) ileostomy closure and intestinal continuity restoration.
    • This approach aims to manage severe and mild pediatric UC effectively.

    Implications:

    • Expanded surgical consideration can improve outcomes for children with refractory ulcerative colitis.
    • The described two-step surgical technique offers a structured approach to bowel reconstruction.
    • Further research into the long-term efficacy and quality of life post-surgery is warranted.

    More Related Videos

    A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium04:05

    A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

    Published on: May 31, 2024

    Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis06:19

    Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

    Published on: May 16, 2025

    Related Concept Videos

    Drugs for Treatment of Ulcerative Colitis in IBD01:29

    Drugs for Treatment of Ulcerative Colitis in IBD

    Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Peptic Ulcer Disease IV: Management01:26

    Peptic Ulcer Disease IV: Management

    Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
    The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
    Pharmacological management
    The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
    Inflammatory Bowel Disease IV: Pharmacological Management01:29

    Inflammatory Bowel Disease IV: Pharmacological Management

    Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
    Pharmacologic...
    Inflammatory Bowel Disease V: Surgical Management01:21

    Inflammatory Bowel Disease V: Surgical Management

    Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
    Here are some common surgical interventions for IBD:
    Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

    Peptic Ulcer Disease V: Surgical Management and Nursing Care

    Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
    Surgical Interventions for Peptic Ulcer Disease